Erdheim-Chester disease in childhood: a challenging diagnosis and treatment. Tran, T. A., Fabre, M., Pariente, D., Craiu, I., Haroche, J., Charlotte, F., Eid, P., Durrbach, A., Taoufik, Y., & Kone-Paut, I. J Pediatr Hematol Oncol, 31(10):782–6, October, 2009.
Erdheim-Chester disease in childhood: a challenging diagnosis and treatment [link]Paper  abstract   bibtex   
Erdheim-Chester disease is a rare, non-Langerhans systemic histiocytosis characterized by bilateral sclerosis of the metaphyseal regions of the long bones and infiltration in other organs. The histopathologic hallmark is defined by a mononuclear infiltrate of foamy histiocytes and rare pathognomonic Touton giant cells with extensive fibrosis. This condition is exceptional in children. We report here a case of Erdheim-Chester disease in a 10-year-old girl with retroperitoneal infiltration and bone involvement, for whom the diagnosis was only established after a 3-year course with multiple biopsies. It is also the first pediatric case successfully treated with interferon-alpha suggesting that interferon-alpha can be a safe and efficient first-line therapy for this disease in children.
@article{tran_erdheim-chester_2009,
	title = {Erdheim-{Chester} disease in childhood: a challenging diagnosis and treatment},
	volume = {31},
	issn = {1536-3678 (ELECTRONIC) 1077-4114 (LINKING)},
	shorttitle = {Erdheim-{Chester} disease in childhood: a challenging diagnosis and treatment},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/19755920},
	abstract = {Erdheim-Chester disease is a rare, non-Langerhans systemic histiocytosis characterized by bilateral sclerosis of the metaphyseal regions of the long bones and infiltration in other organs. The histopathologic hallmark is defined by a mononuclear infiltrate of foamy histiocytes and rare pathognomonic Touton giant cells with extensive fibrosis. This condition is exceptional in children. We report here a case of Erdheim-Chester disease in a 10-year-old girl with retroperitoneal infiltration and bone involvement, for whom the diagnosis was only established after a 3-year course with multiple biopsies. It is also the first pediatric case successfully treated with interferon-alpha suggesting that interferon-alpha can be a safe and efficient first-line therapy for this disease in children.},
	number = {10},
	journal = {J Pediatr Hematol Oncol},
	author = {Tran, T. A. and Fabre, M. and Pariente, D. and Craiu, I. and Haroche, J. and Charlotte, F. and Eid, P. and Durrbach, A. and Taoufik, Y. and Kone-Paut, I.},
	month = oct,
	year = {2009},
	keywords = {Bone, Cell, Child, Disease/*diagnosis/*drug, Diseases, Erdheim-Chester, Female, Humans, Induction, Interferon-alpha/therapeutic, Movement, Remission, Therapy, use},
	pages = {782--6},
}

Downloads: 0